Trademark: 75215282
Status Date
Saturday, June 6, 2009
Registration Number
2643087
Registration Date
Tuesday, October 29, 2002
Filing Date
Wednesday, December 18, 1996
Published for Opposition
Tuesday, September 23, 1997
Cancellation Date
Saturday, June 6, 2009
5 pharmaceutical compounds that act on the central nervous system to treat neurodegenerative diseases and conditions such as memory deficits associated with Alzheimer's disease, impairment associated with the dementia of aging, stroke, and the neurological aspects of AIDS, as well as spinal cord injuries, expressly excluding pharmaceuticals for the treatment of amyotrophic lateral sclerosis, multiple sclerois and/or peripheral neuropathy
Jun 6, 2009
Cancelled Sec. 8 (6-Yr)
Jan 21, 2009
Attorney Revoked And/Or Appointed
Jan 21, 2009
Teas Revoke/Appoint Attorney Received
Feb 19, 2008
Case File In Ticrs
Sep 5, 2007
Automatic Update Of Assignment Of Ownership
Oct 29, 2002
Registered-Principal Register
Jul 19, 2002
Allowed Principal Register - Sou Accepted
Jul 8, 2002
Assigned To Examiner
Jul 2, 2002
Statement Of Use Processing Complete
May 15, 2002
Use Amendment Filed
Jun 5, 2002
Extension 3 Granted
Jan 18, 2002
Extension 3 Filed
Oct 28, 2001
Extension 2 Granted
Jun 14, 2001
Extension 2 Filed
Apr 10, 2001
Extension 1 Granted
Jan 18, 2001
Extension 1 Filed
May 28, 2002
Petition To Revive-Granted
Jun 14, 2001
Petition To Revive-Received
Jun 4, 2001
Abandonment - No Use Statement Filed
Jul 18, 2000
Noa Mailed - Sou Required From Applicant
May 30, 2000
Opposition Terminated No. 999999
May 30, 2000
Opposition Dismissed No. 999999
Mar 5, 1998
Opposition Instituted No. 999999
Oct 21, 1997
Extension Of Time To Oppose Received
Sep 23, 1997
Published For Opposition
Aug 22, 1997
Notice Of Publication
Jul 16, 1997
Approved For Pub - Principal Register
Jul 8, 1997
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
